Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON49218
NL-OMON49218
Recruiting
Not Applicable

The Impact of Telemonitoring on correct drug Use, complications and quality of life among patients with Multiple Myeloma (MM);(ITUMM) - Telemonitoring among patients with multiple myeloma

Isala Klinieken0 sites150 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshaematological cancermultiple myeloma10018849

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
haematological cancer
Sponsor
Isala Klinieken
Enrollment
150
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Isala Klinieken

Eligibility Criteria

Inclusion Criteria

  • •In order to be eligible to participate in this study, with informed consent, a
  • •subject (patient) must meet all of the following criteria:
  • •Patients meeting any of the following criteria may be included in the study:
  • •Females and males \>\*18 years;
  • •Diagnosis of multiple myeloma (NDMM patients);
  • •Able to complete outcome measures;
  • •Patients will be screened on minimal digital skills to check if they are able
  • •to interact with an e\-coach and whether they can read and understand the Dutch
  • •language; estimated by the patient\*s haematologist/oncologist
  • •Patients have their own mobile (smart)phone, computer or tablet (20 iPads are

Exclusion Criteria

  • •potential subject who meets any of the following criteria will be excluded from
  • •participation in this study:
  • •Not prescribed oral medication for a MM treatment regime;
  • •Psychiatric illness requiring secondary care intervention;
  • •Too ill to engage with the intervention in the opinion of the clinical care

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Influence of therapeutic drug monitoring (TDM) on the tolerability and efficacy of 5-FU-containing chemotherapy in patients with colorectal carcinoma in the colorectal center at St.-Franziskus-Hospital Münster: a prospective, monocentric observational study.C18Malignant neoplasm of colon
DRKS00026926St. Franziskus-Hospital GmbH50
Recruiting
Not Applicable
Telemonitoring Among Patients With Multiple MyelomaMultiple Myeloma
NCT05964270Isala150
Active, not recruiting
Not Applicable
Effectiveness of theraPeutic drug mOnitoring (TDM) on mucosal and transmural healing in pediatric patients with moderate to severe luminal CroHn’s disease newly receiving Remsima(infliximab): EPOCH studyDiseases of the digestive system
KCT0005190Samsung Medical Center116
Not yet recruiting
Not Applicable
Het effect van electronisch gegenereerde feedback over reumageneesmiddelen bij patiënten met reumatoïde artritisAdherence, Electronic Monitoring, Rheumatoid Arthritis, Disease activityTherapietrouwReumatoïde arthritisziekteactiviteit
NL-OMON26997Sint Maartenskliniek Hengstdal 36101 HB Nijmegenthe NetherlandsB Benraad, Director Department of Pharmacy Sint Maartenskliniek168
Completed
Not Applicable
Special drug use results surveillance for the use of SIMPONI in ulcerative colitisulcerative colitis
JPRN-UMIN000027542Janssen Pharmaceutical K.K.300